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Attention-deficit hyperactivity disorder (ADHD) was first thought
to be a disorder only present in childhood; however, it is now
recognised as a persistent disorder into adulthood. Thus far, most
studies in adulthood concern young or middle-aged adults,
whereas little is known about ADHD in old age. Attention-deficit
hyperactivity disorder affects 3% to 7% of school-aged children,1
and the estimated prevalence of adult ADHD is marginally lower
at 4.4%.2 However, older adults were not included in these
prevalence studies. As far as we know, only one study included
older adults in their prevalence estimates. This study estimated
the ADHD prevalence in The Netherlands to be 1–2.5% among
adults between 18 and 75 years of age, without any signs of decline
in the older age groups.3 Only one study focused on childhood
ADHD in older adults aged 65–80 years: a prevalence of 3.3%
of childhood ADHD was found.4
Attention-deficit hyperactivity disorder has a profound
impact on the lives of adults. Those afflicted often work below
their intellectual level, have problems in relationships and social
contacts, have problems organising their daily lives, are more
likely to have accidents, more often have comorbid psychiatric
disorders and more often display antisocial behaviour compared
with adults without ADHD.5–8 Attention-deficit hyperactivity
disorder might also lead to significant impairment in older age
and the first step towards establishing possible needs for treatment
for this disorder in older adults is to have credible data on its
prevalence. Therefore, the objective of the present study was to
estimate the prevalence of ADHD and the prevalence of ADHD
subtypes in the general older population aged 60–94 years in
The Netherlands. The expectation was that ADHD would not
disappear in later life. Earlier research showed slightly lower
prevalence rates of ADHD among adults than among children1,2
and the expectation therefore was that the prevalence rate among
older adults would be lower than the prevalence rates in children
and younger adults.
Method
Study sample
Data for the present study were collected in the Longitudinal
Aging Study Amsterdam (LASA), an ongoing study of changes
in autonomy and well-being with ageing in The Netherlands. Full
details on sampling are described elsewhere.9 In summary, a
random sample of older men and women (55–85 years), stratified
by age and gender, was drawn from the population registries of 11
municipalities in 3 geographical areas of The Netherlands. Data
collection started in 1992–1993 (n= 3107), with respondents born
in 1908–1937 (cooperation rate 62%). Further follow-ups were
carried out in 1995–1996 (n= 2545), 1998–1999 (n=2076) and
2001–2002 (n=1691). In 2002–2003, a new cohort was sampled
(birth years 1938–1947, n= 1002) from the same sampling
frame as the earlier cohort. Both samples were combined and a
follow-up was carried out in 2005–2006 (n= 2165). Cumulative
attrition during the 16 years of follow-up in LASA was mainly
caused by death (76%) and to a lesser extent by refusal (14%)
and frailty or no establishment of contact (10%).9 Every measure-
ment wave consists of two parts. The first part is the main
interview, where topics such as social network and religion were
assessed. During the main interview respondents were asked to
participate in a subsequent nurse interview, where mostly medical
topics were assessed. Interviews were conducted in the homes of
the participants. In the present study, data were used from the
follow-up in 2008–2009 (n=1601). The ADHD screening list
was part of the nurse interview (n= 1494). Attrition between the
main and medical interview (6.9%) was due to refusal (n=86),
frailty (n= 13), death (n= 4) and not being able to contact the
person (n=4). Specially trained and intensively supervised
interviewers conducted the main and nurse interviews. Informed
consent was obtained from all participants, and the study was
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Background
Little is known about the prevalence of attention-deficit
hyperactivity disorder (ADHD) among older adults.
Aims
To estimate the prevalence of the syndromatic and
symptomatic DSM-IV ADHD diagnosis in older adults in
The Netherlands.
Method
Data were used from the Longitudinal Aging Study
Amsterdam (LASA). At baseline, 1494 participants were
screened with an ADHD questionnaire and in 231
respondents a structured diagnostic interview was
administered. The weighted prevalence of ADHD was
calculated.
Results
The estimated prevalence rate of syndromatic ADHD in older
adults was 2.8%; for symptomatic ADHD the rate was 4.2%.
Younger elderly adults (60–70 years) reported significantly
more ADHD symptoms than older elderly adults (71–94
years).
Conclusions
This is the first epidemiological study on ADHD in older
persons. With a prevalence of 2.8% the study demonstrates
that ADHD does not fade or disappear in adulthood and that
it is a topic very much worthy of further study.
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Measures
ADHD
Attention-deficit hyperactivity disorder was screened using a
questionnaire developed by Barkley et al.10 The questionnaire
consists of seven items on inattention, one item on hyperactivity
and one item on impulsivity. Using two response categories (no/
yes), the sum score varied from 0 to 9 (0 = no symptoms of
ADHD, 9 = all symptoms of ADHD). This questionnaire was
translated into Dutch and back-translated into English by
independent translators. In our group, Semeijn et al11 found that
the questionnaire had acceptable qualities, with good sensitivity
and an area under the curve (AUC) which is in concordance with
the AUC (0.86) found among adults.12
To diagnose ADHD, the Diagnostic Interview for ADHD in
Adults, second edition, (Diagnostisch Interview Voor ADHD bij
volwassenen, DIVA 2.0) was used.13 This semi-structured
interview consists of two parts: one for assessing the presence of
all 18 DSM-IV-TR criteria1 in childhood (primary school, age
6–12) and at the current time; the other to assess impairment
in five areas of functioning (work, education, family, social/
relationships and self-confidence) in childhood and at present,
related to the ADHD symptoms. The DIVA 2.0 has not yet been
validated in (older) adults, but as it is based on the DSM-IV-TR
criteria,1 we expect the validity to be high.3
For the present study, the DIVA 2.0 was modified into a
structured diagnostic interview because LASA works with lay
interviewers. Examples of behaviour often reported by adults with
ADHD were added with each symptom. An example of a question
is ‘Do you often find it difficult to keep your attention; for
example, are you distracted easily by your own thoughts, do you
find it difficult to watch a film through to the end, or to read a
book?’ (answer no/yes). When participants endorsed a symptom,
either at the present time or in childhood, further questions were
asked about the duration (‘Longer than 6 months?’, no/yes), fre-
quency (‘More than once a week?’, no/yes), and whether the symp-
tom persisted throughout their life. In part two it was asked
whether the symptoms led to impairment in different areas of
functioning, both in adulthood and during childhood. A stem
question about impairment in one area was first asked and, when
given a negative answer, several more specific examples of
impairment were given. These questions also had to be answered
with yes or no. Additional impairment could be reported by the
respondent. An area was scored as impaired when two or more
examples in an area were answered affirmatively. Interviewers were
adequately trained to evaluate the answers to the questions of the
structured interview. The interviewers received 8 h of training and
practised one interview before the study. The authors (M.M. and
E.S.) intensively supervised all interviews, and questions were
discussed with an experienced psychiatrist (J.J.S.K.).
In the literature for measuring the persistence of ADHD from
childhood to adulthood, different persistence rates are used.14 The
first is the syndromatic persistence rate, the maintenance of the
full diagnostic status; the second is the symptomatic persistence
rate, the maintenance of partial diagnostic status with impairment.
A syndromatic diagnosis of adult ADHD required six symptoms
or more of either inattention and/or hyperactivity–impulsivity
during the 6 months prior to the interview (DSM-IV-TR criterion
A). Symptomatic ADHD required the cut-off score of four
symptoms or more of either inattention and/or hyperactivity–
impulsivity during the 6 months prior to the interview.3
Following the DSM-IV-TR criteria, a distinction was made
between the three ADHD subtypes.
(a) The predominantly inattentive subtype (ADHD-IA) required
six (syndromatic) or four (symptomatic) inattention
symptoms and fewer than six or four symptoms of the
hyperactive–impulsive domain during the 6 months prior to
the interview.
(b) The predominantly hyperactive–impulsive subtype (ADHD-HI)
required six (syndromatic) or four (symptomatic) hyperactivity–
impulsivity symptoms and fewer than six or four symptoms of
the inattention domain during the 6 months prior to the
interview.
(c) The combined subtype (ADHD-C) required six (syndromatic)
or four (symptomatic) inattention symptoms and six or four
hyperactive–impulsive symptoms during the 6 months prior
to the interview.
For all diagnoses it was required to have six symptoms of
either inattention and/or hyperactivity–impulsivity in childhood
(DSM-IV-TR criterion A). It was also required to have clinically
significant impairment in at least two areas of daily life during
the past 6 months prior to the interview and in childhood
(criterion C and D). No attempt was made to operationalise
DSM-IV-TR criterion E, which states that the symptoms are not
better accounted for by another mental disorder.
To analyse differences in demographic characteristics the
sum score of all current and childhood ADHD symptoms was
calculated (range 0–36).
Demographic characteristics
The demographic characteristics included gender (male, female),
age (based on the median, 60–70 and 71–94 years), living status
(living together with partner or alone), urban environment
(Amsterdam or elsewhere) and socioeconomic status (education
and monthly income). Categories for education were: low
(elementary education or less,46 years), medium (general, inter-
mediate and lower vocational education, 7–11 years) and high
(university, college, higher vocational education, 511 years).
For monthly net household income, three categories (tertiles),
in Euros, were distinguished: low (e1350), medium (between
e1350 and 4e1929) and high (5e1929). For participants with a
partner living in the household, household income was multiplied
by 0.7 to make it comparable with the income in a one-person
household.15 Income data were missing for 16 respondents.
Procedure
In order to limit the number of diagnostic interviews, a two-phase
non-proportional stratified random sampling procedure was used
(Fig. 1). In the first phase, 1494 participants responded on the
screening questionnaire for ADHD: 45 respondents were excluded
owing to too many missing values (53), and 467 respondents
were unavailable for further participation because of participation
in another side study. These respondents were randomly chosen –
there were no specific inclusion or exclusion criteria, therefore the
ADHD study sample is not likely to be biased by excluding these
respondents.
Three exclusion criteria were implemented. First, low cognitive
functioning, measured with the Mini-Mental State Examination,16
a frequently used screening instrument for global cognitive
dysfunction. The scale consists of 23 items and scores range from
0 to 30, with higher scores indicating better cognitive functioning.
Respondents with an MMSE score 418 were excluded. Second,
those who experienced cognitive decline, which was defined as a
299
ADHD in older adults in The Netherlands
Michielsen et al
difference in score of more than one standard deviation on the
MMSE (53 points) over a period of 3 years were excluded.
Finally, respondents with a history of cerebrovascular accident
were excluded.
The first phase consisted of 1449 respondents. Based on the
score on the ADHD screening questionnaire the sample was
divided into three groups. The screening list has not yet been
validated among older adults; therefore the best cut-off score for
older adults is unknown. To ensure sufficient power and equal
group sizes, the total score on the screening list of the high scoring
group, most likely to have ADHD, was set at 3–9. The moderate
scoring group was set at a total score between 1 and 2, and the
low scoring group was set at a total score of 0. In phase 2, all
of the participants in group 3, and a random sample of the
participants in groups 1 and 2 (n=271), were approached for a
diagnostic interview. The randomisation was done by means
of the random number generator using the Statistical Package
for Social Sciences (SPSS) software version 15.0 for Windows. In
total, 94 respondents of the low scoring group, 93 of the moderate
scoring group and 84 respondents of the high scoring group were
approached; 85 (90%), 80 (86%) and 69 (82.3%) respectively
consented to be interviewed. Three respondents were excluded
from statistical analysis: one participant refused to answer
questions about childhood because of experienced trauma during
that period; the second participant had a cerebrovascular accident
and was not able to answer the questions; the third participant was
not able to recollect childhood memories. Thus, the study sample
consisted in total of n = 231. Respondents who participated in the
phase 2 (interview) were significantly younger (mean 71.6 years,
s.d. = 7.7) than those who participated in phase 1 (mean 73.4
years (s.d. = 8.5); t(341,8) =73.095, P=0.002). There were no
significant differences in gender between those who participated
in phase 2 and those who did not. All interviews were conducted
between May and September 2010. The interviewers were masked
to the initial results of the screening questionnaire.
Statistical analysis
The prevalence of ADHD was computed according to the two-
phase sampling model. The data were weighted for sampling
probability. The sampling weight is an indicator of how many
phase 1 respondents were represented by each of the phase 2
respondents. The values are the reciprocal of the sampling
fractions. The prevalence was then weighted back to the general
older population, by comparing the study sample of 1449
respondents with population-based numbers from Statistics
Netherlands regarding age and gender. Afterwards the weights
were scaled back to the study sample (n= 231). Weighted
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Fig. 1 Flowchart of screeining and diagnostic interview phases. CVA, cerebrovascular accident; MMSE, Mini-Mental State Examination.
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prevalence rates were calculated with STATA version 10 for
Windows. Independent t-tests (two-tailed) and ANOVA were
conducted with SPSS.
Results
Descriptive statistics of the respondents are presented in Table 1.
Of the 231 respondents, 137 were female (59%) and 97 (41%)
were male. The average age was 71 years (s.d. = 7.7, range 60–
94), more than half of the respondents were living together with
their partner (63%).
Weighted back to the general population, the prevalence rate
of syndromatic ADHD was estimated at 2.8% (95% CI 0.86–
4.64) and the prevalence of symptomatic ADHD at 4.2% (95%
CI 2.05–6.39) (Table 2). At face value, the prevalence was higher
in younger elderly adults compared with older elderly adults
(4.0% v. 1.1% for syndromatic and 5.8% v. 2.1% for symptomatic
ADHD), but the prevalence rates in the different age groups
were not tested for significance owing to the small sample
size. However, independent samples t-test showed that younger
elderly adults reported significantly more ADHD symptoms
(mean 6.91, s.d. = 6.0) than older elderly adults (mean 4.78
(s.d. = 4.79); t(227,3) = 3.00, P=0.003) (Table 3). There was no
significant difference in ADHD symptoms between men and
women, by living situation, level of education or level of income.
The difference in prevalence rates of the syndromatic and
symptomatic subtypes between genders and age groups was not
tested for significance owing to the small sample sizes. On face
value, the prevalence rates for the syndromatic subtypes ADHD-
HI and ADHD-C were slightly higher among men than women;
it was only for the inattention subtype that the prevalence rate
was higher among women than men (Table 4). The prevalence
rates for the symptomatic subtypes were only different for
ADHD-HI: the rate was higher among men than women. The
prevalence rates were higher for all subtypes in the younger elderly
group compared with the older elderly group.
An important DSM-IV-TR ADHD criterion is that ADHD
should lead to impairment in at least two areas of functioning.
Respondents with both syndromatic and symptomatic ADHD
described impairments due to the reported symptoms in 3.7 of
the 5 areas in childhood and 4.4 areas of functioning at the present
time.
Discussion
This study is the first to report on the prevalence rates of ADHD
in older adults. It was estimated that 2.8% of older adults have
full-blown, syndromatic ADHD and 4.2% symptomatic ADHD.
This correlates roughly with 95000 older adults in The Netherlands
who have syndromatic ADHD, and 145 000 older adults who have
symptomatic ADHD. People with syndromatic or symptomatic
ADHD reported impairment due to the symptoms in several areas
of functioning, meaning that ADHD remains an important cause
of impairment in old age.
With these prevalence rates, we have to take into consideration
that the diagnostic instruments were not yet validated in (older)
adults. However, as expected, these prevalence rates are a bit lower
than the prevalence rates of ADHD in children (3–7%)1 and
adults (4.4%).17 In contrast to most prevalence studies among
children and adults where ADHD is more prevalent among
men, in our study men and women reported similar levels of
ADHD symptoms.17–21 This may be a surprising result, although
some studies in adults also found similar prevalence estimates
between genders.3 It may be that the prevalence rates of genders
converge over the life course, but more research is necessary to
further explore this finding.
In this study the prevalence rates of the different subtypes of
ADHD were estimated to examine whether symptoms of ADHD
change over the life course. Among children, only considering
studies among community-based samples, ADHD-IA is most
common (4.5–5.4%) compared with 1.7–2.4% for ADHD-HI
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Table 1 Unweighted demographic characteristics of the study sample
Total N=231 Syndromatic ADHDa n=14 Symptomatic ADHDb n=23 No ADHDc n=208
Characteristic N n % n % n %
Gender
Male 94 7 50.0 11 47.8 83 39.9
Female 137 7 50.0 12 52.2 125 60.1
Age, years
60–70 116 9 64.3 15 65.2 101 48.6
71–94 115 5 35.7 8 34.8 107 51.4
Living together
Yes 145 8 57.1 12 52.2 133 63.9
No 86 6 42.9 11 47.8 75 36.1
Urban residence
Amsterdam 34 3 21.4 6 26.1 28 13.5
Elsewhere 197 11 78.6 17 73.9 180 86.5
Educational level
Low 73 7 50.0 10 43.5 63 30.3
Medium 71 2 14.3 6 26.1 65 31.3
High 87 5 35.7 7 30.4 80 38.4
Income leveld
Low 77 4 30.8 9 40.9 68 35.2
Medium 62 3 23.1 5 22.7 57 29.5
High 76 6 46.2 8 36.4 68 35.2
ADHD, attention-deficit hyperactivity disorder.
a. 56 symptoms of inattention and/or hyperactivity–impulsivity at present time and in childhood.
b. 54 symptoms of inattention and/or hyperactivity–impulsivity at present time and 56 symptoms of inattention and/or hyperactivity–impulsivity in childhood.
c. Respondents having no syndromatic or symptomatic ADHD.
d. Data missing for 16 individuals.
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and 1.9–3.6% for ADHD-C.19,22,23 A community-based study
among younger adults estimated prevalence rates of 1.3% for
ADHD-IA, 2.5% for ADHD-HI and 0.9% for ADHD-C.22 In
our study, a similar order of prevalence rates was found for the
three different subtypes; ADHD-C was the least prevalent and
the prevalence rate of ADHD-IA was estimated at 1.1%, a bit
lower than the prevalence estimate of the study among younger
adults. In contrast to the estimated prevalence rates among
adults, where ADHD-HI was found to be the most prevalent,
the prevalence rates of ADHD-IA and ADHD-HI were
almost the same in our study. Looking at the three age
groups of community-based respondents with ADHD, it seems
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Table 2 Estimated weighted prevalence rates of attention-deficit hyperactivity disorder (ADHD) among men and women and
different age groups
Total syndromatic ADHDa (unweighted n=14) Total symptomatic ADHDb (unweighted n=23)
Weighted
n % 95% CI
Estimated
n
Weighted
n % 95% CI
Estimated
n
Total 6 2.8 0.86 to 4.65 97 876 10 4.2 2.05 to 6.39 146 814
Gender
Men 3 3.0 70.19 to 6.11 41 373 5 4.6 0.96 to 8.39 68 425
Women 3 2.6 0.38 to 4.72 49 512 4 3.8 1.39 to 6.24 64 745
Age, years
60–70 5 4.0 0.75 to 7.23 67 958 8 5.8 2.19 to 9.44 107 301
71–94 1 1.1 0.18 to 1.96 17 072 2 2.1 0.55 to 3.55 34 144
a. 56 symptoms of inattention and/or hyperactivity–impulsivity at present time and in childhood.
b. 54 symptoms of inattention and/or hyperactivity–impulsivity at present time and 56 symptoms of inattention and/or hyperactivity–impulsivity in childhood.
Table 3 Weighted differences of demographic characteristics on total score of attention-deficit hyperactivity (ADHD) symptoms
Total score ADHD symptoms (0–36)a
n Mean s.d. t F d.f. P
Gender 0.42 229 0.68
Male 115 6.16 5.28
Female 116 5.85 5.93
Age, years 2.99 227 0.003
60–70 133 6.91 6.00
71–94 98 4.78 4.79
Living together 71.14 229 0.26
No 68 5.36 5.69
Yes 163 6.28 5.56
Urban residence 71.00 229 0.32
Amsterdam 35 6.88 5.66
Elsewhere 196 5.85 5.60
Education 1.26 2 0.29
Low 64 6.88 6.41
Middle 69 5.35 5.55
High 99 5.91 5.05
Income 0.06 2 0.94
Low 67 5.98 5.84
Middle 62 6.01 5.30
High 89 5.72 5.61
a. This is the sum score of all inattention and hyperactive–impulsive symptoms at the present time and in childhood.
Table 4 Estimated weighted prevalence of the different attention-deficit hyperactivity disorder subtypes among men and women
and different age groups
Subtype
inattentive
syndromatic
Unweighted n=6
Subtype
hyperactive
syndromatic
Unweighted n=5
Combined subtype
syndromatic
Unweighted
n=3
Subtype inattentive
symptomatic
Unweighted
n=7
Subtype hyper-
active symptomatic
Unweighted
n=4
Combined subtype
symptomatic
Unweighted
n=12
Weighted
n %
Weighted
n %
Weighted
n %
Weighted
n %
Weighted
n %
Weighted
n %
Total 3 1.1 3 1.3 1 0.4 3 1.2 2 0.7 5 2.4
Men 0 – 2 1.7 1 0.9 1 0.9 1 0.9 3 2.6
Women 2 1.7 1 0.9 0 – 1 0.9 0 – 3 2.6
Age , years
60–70 2 1.5 2 1.5 1 0.7 2 1.5 2 1.5 4 3.0
71–94 0 – 0 – 0 – 1 1.0 0 – 1 1.0
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that all three subtypes are more prevalent among children. The
hyperactivity–impulsivity prevalence seems to peak in adults
and to decline in older age. The inattention subtype does not seem
to change after adulthood, whereas ADHD-C seems to decline
over the life course. Care must be taken with inference on the
course of ADHD over the life course; so far our study is the only
study researching these subtypes in older adults, and more,
preferably longitudinal, studies are necessary to get a clear insight
into ADHD and its development over the life course.
An additional interesting finding in our study is that younger
elderly adults (60–70 years) reported more ADHD symptoms
compared with older elderly adults (71–94 years). A possible
explanation may be that the symptoms diminish with increasing
age. The specific (biological) mechanisms behind this decrease
of symptoms are unknown. Another explanation may be that
the diagnostic interview used is not sensitive enough to detect
ADHD in older elderly adults. A final possible explanation for
the lower levels of ADHD symptoms found at age 71 and over
may be that persons with ADHD have a lower life expectancy
compared with people with no ADHD. The disorder is associated
with increased morbidity and with other psychiatric disorders
such as substance use disorder, depression and anxiety
disorders.24,25 Furthermore, an almost fourfold increase in average
frequency of being involved in accidents as drivers was reported by
young adults with ADHD.26 These factors might have a negative
influence on the life expectancy of people with ADHD and may
explain the lower prevalence rates among older elderly adults.
Another striking finding is that older adults with ADHD did
not differ in living situation, level of education and income
compared with older adults without ADHD. Given the chronicity
and impact of the ADHD, one might have expected that older
adults with ADHD would experience impairments in these three
areas. There are several explanations for this finding. First,
although we did not find any objective differences in these three
areas, our respondents with ADHD did however report a negative
impact of the ADHD symptoms on four out of five areas of
functioning, currently and in childhood. It may be that owing
to the small sample that the differences in the three areas did
not reach statistical significance. Second, a recent study among
community-dwelling older adults with ADHD also did not find
a lower income among older adults with ADHD.27 It may be that
older adults with ADHD do not differ in income level compared
with older adults without ADHD. Third, education is not directly
related to ability in the older age group. Many able older adults
did not have the opportunity to study in their childhood; there-
fore low level of education may not be a distinctive characteristic
of older people with ADHD. Finally, the respondents may be
looked upon as survivors and represent a subsample of relatively
successful and higher functioning older adults with ADHD.
Limitations
Diagnosing ADHD in older adults comes with several limitations.
Our diagnostic instrument is based on the DSM-IV-TR criteria as
developed for children, and has not yet been validated in (older)
adults. Clinical observations have shown that symptoms of ADHD
are different in adults than in children, although not less
impairing. Consequently, in the past few years, a number of
researchers have questioned the validity of this diagnosis in
adults.28,29 New suggestions for the adjustment of the adult
ADHD diagnosis have been proposed, such as a new questionnaire
mainly asking about executive functioning10 and a reduction in
the cut-off for diagnosis using DSM-IV.3 How the symptoms of
ADHD develop in older adults is unknown, however it seems
likely that symptoms of ADHD might be different for older people
too. Weiss describes possible challenges ADHD presents to older
adults,30 such as an increase in cognitive impairments that were
previously compensated for by coping mechanisms. This could
mean that the DSM-IV-TR criteria currently used may not be
subtle enough for diagnosing ADHD in older adults. More
research is needed in this area. The semi-structured DIVA (2.0)
was modified into a fully structured interview for this study.
Although it is unknown what the effect of this may have been
on the results, previous studies have shown that fully structured
interviews such as the Composite International Diagnostic
Interview do very well in some disorders, such as anxiety disorders
and depression,31 while they tend to underestimate the prevalence
of others, such as bipolar disorder.32 Under- or overestimation
may also be the case here, meaning that the prevalence of ADHD
based on the fully structured interview should be interpreted with
some caution.
In addition, in our study other psychiatric disorders were not
included in the diagnostic interview. A cross-sectional study of
age-related changes in ADHD symptoms in a clinical sample
diagnosed with ADHD (ages 16–50 years) found that older adults
reported more depressive symptoms and inattentive symptoms,
whereas inattentive symptoms improved according to
informants.33 The subjective increase of attention symptoms
may be associated with depression. This could mean that possible
affective symptoms present in older persons in our study may
have led to misdiagnosis. However, a respondent would only
receive an ADHD diagnosis in our study when six out of nine
ADHD symptoms were already present in childhood. This
childhood onset and lifetime persistence of symptoms and
impairment should filter out the false positives. Since we did
not include other psychiatric disorders, the prevalence rate should
be interpreted with some caution and further research on ADHD
and comorbid disorders in older adults is needed.
Another limitation regards the recollection of childhood
symptoms. Since external reports, from informants and/or school
reports were not available in our study, the ADHD diagnosis relied
solely on the respondents’ recollection of childhood symptoms.
Studies on concordance between recollection of patients with
ADHD and recollection of informants have shown inconsistent
results; most studies showed an underestimation of childhood
symptoms among children and young adults,34–37 although one
study found that recollection by the participant produced
overestimation,29 while two other studies found that adults with
ADHD can be just as reliable in reporting (attention) problems
as informants.38,39 More research on linking childhood school
reports with measures of ADHD in older adults is needed.
Finally, the analyses were carried out in the sixth cycle of an
ongoing study covering 16 years, which inevitably involved
attrition of participating respondents. Attrition in the LASA
cohort can be attributed for the largest part to mortality9 but
attrition due to mortality does not necessarily influence the
representativeness of the sample9 since high mortality is a
characteristic of older populations. Attrition due to frailty in
LASA was associated with poorer self-rated health. Conversely,
attrition due to refusal was associated with better health.40 As very
little is known about the determinants of ADHD in older people,
it is difficult to estimate the effect any selective loss of respondents
may have had. Since the prevalence was weighted back to the
general Dutch older population regarding age (and gender), our
expectation is that attrition did not bias the prevalence rate.
Clinical implications
This is the first epidemiological study, systematically studying
ADHD in the general older population, using a diagnostic
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interview. Although many unresolved issues remain, the study
demonstrates clearly that ADHD does not fade or disappear in
older age and it is a topic very much worthy of further study.
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The Patella Hammer
Michael Henry
Family legend has it he packed it
in his rucksack to hammer in tent-pegs
when he went hiking in the Zugspitze.
Almost an international incident –
Liverpool medic stranded in Germany
at the outbreak of war.
Where his ancestors quarried stone
he worked in bone – trading their crude tools
for something neat and silver.
He tapped my childish reflexes –
mostly in fun – always
the same knee-jerk reaction.
Once when my injured leg unnumbed
he placed a football at my foot
and tapped my knee-cap
and when I kicked the ball
he clapped and clapped as if
I’d scored a goal for England.
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